Marketing Pharmaceuticals 2016

Discuss the complexity of marketing and how to promote pharmaceuticals, biologics, and medical devices in an effective yet compliant manner in an evolving environment.

戻る Agenda

Session 6: Using New and Emerging Technologies Compliantly

Session Chair(s)

Dale Cooke, JD, MA

President

Phillycooke Consulting, United States

Consumer and health care professionals are adopting new technology platforms, especially mobile and social, as their preferred means of accessing information, yet pharmaceutical manufacturers have found it difficult to ensure their messaging meets FDA regulations in these platforms. This session explores the experience of some of the industry's leading companies in overcoming these challenges while ensuring compliance with FDA regulatory requirements.

Speaker(s)

Panelists

Matthew Boyd, MBA

Sobi Inc., United States

Vice President Head of Regulatory North America

Laura Kolodjeski

Sanofi, United States

Director, Digital Strategy & Operations

Brook Yohannes, PharmD

Shire, United States

Manager, Promotional Regulatory Affairs

Yemisi Oluwatosin, PhD

Astrazeneca Pharmaceuticals, United States

Director, Regulatory Affairs Promotional Review